SEELY LYNN sold 9.7% of their position (7.26K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $76.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/22/2025ACC: 0001415889-25-022747
+32.74K
Net shares
Net buyer
$76.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
40K acquired · 7.26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+40K
Price / share
—
Trade value
—
% of position
114.9%
8/20/2025
34.83K→74.83K
Common Stock
Direct
Shares
−7.26K
Price / share
$10.54
Trade value
$76.52K
% of position
9.7%
8/21/2025
74.83K→67.57K
Total
Net shares
+32.74K
Net value
-$76.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/20/2025 | A · Award | +40K | — | — | 114.9% | 34.83K | 74.83K |
| Common Stock Direct | 8/21/2025 | S · Sale | −7.26K | $10.54 | $76.52K | 9.7% | 74.83K | 67.57K |
| Total | +32.74K | -$76.52K | ||||||
Derivative Transactions0
No derivative transactions reported